rivastigmine tartrate

FDA Drug Profile

rivastigmine tartrate is listed in the FDA National Drug Code directory with 1 NDC code. Available dosage form: powder.

Drug Details

Generic Name
rivastigmine tartrate
Brand Names
N/A
Application Number
Sponsor
Jubilant Biosys limited
NDC Codes
1
Dosage Forms
POWDER
Routes
N/A
Active Ingredients
RIVASTIGMINE TARTRATE

Indications and Usage

1 INDICATIONSAND USAGE Rivastigmine tartrate is an acetylcholinesterase inhibitor indicated for treatment of: • Mild-to-moderate dementia of the Alzheimer's type (AD) ( 1.1 ) • Mild-to-moderate dementia associated with Parkinson's disease (PD) ( 1.2 ) 1.1 Alzheimer's Disease Rivastigmine tartrate capsules, USP are indicated for the treatment of mild-to-moderate dementia of the Alzheimer's type (AD). 1.2 Parkinson's Disease Dementia Rivastigmine tartrate capsules, USP are indicated for the treatment of mild-to-moderate dementia associated with Parkinson's disease (PD).